Search clinical trials for: ION582

Total 3 results

Ionis Pharmaceuticals, Inc.
Biogen

Active, not recruiting

HALOS: A Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of Multiple Ascending Doses of ION582 in Participants With Angelman Syndrome

Angelman Syndrome

United States, Israel, Italy, France, Australia, United Kingdom
Ionis Pharmaceuticals, Inc.
M.D. Anderson Cancer Center

Completed

A Study of ION537 in Patients With Molecularly Selected Advanced Solid Tumors

Advanced Solid Tumors

United States
Ionis Pharmaceuticals, Inc.

Completed

A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Doses of ION547

Healthy Volunteers

Canada

3

Subscribe